Jade Biosciences (JBIO) Assets (2020 - 2026)
Jade Biosciences' Assets came in at $472.11 million for Q2 2026, up 110.8% from $223.97 million a year earlier and up 47.8% from the prior quarter.
Powered by 
Analysis
Jade Biosciences (JBIO) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Jade Biosciences' Assets was $349.78 million, up 380.5% from FY2024.
- Assets carries a five-year compound annual growth rate of 136.6% (FY2020 to FY2025).
- Going back by year, Assets was $72.8 million in FY2024 (-42.9%), $127.42 million in FY2023 (-5.8%), $135.3 million in FY2022 (-22.8%) and $175.36 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Assets in data going back to Q4 2020.
- Year-over-year, Assets has increased for five consecutive quarters, with growth averaging 115.1% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q4 2025 (growth of 380.5%), and the weakest in Q4 2024 (a decline of 42.9%).
- Business Quant data shows JBIO's Assets at $319.43 million (Q1 2026), $349.78 million (Q4 2025) and $202.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Jade Biosciences | 912.03 Mn | 912.03 Mn | - | 472.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 472.11 Mn |
| Mar 31, 2026 | 319.43 Mn |
| Dec 31, 2025 | 349.78 Mn |
| Sep 30, 2025 | 202.45 Mn |
| Jun 30, 2025 | 223.97 Mn |
| Mar 31, 2025 | 77.53 Mn |
| Dec 31, 2024 | 72.80 Mn |
| Sep 30, 2024 | 90.96 Mn |
| Jun 30, 2024 | 111.69 Mn |
| Mar 31, 2024 | 106.82 Mn |
| Dec 31, 2023 | 127.42 Mn |
| Sep 30, 2023 | 140.88 Mn |
| Jun 30, 2023 | 155.76 Mn |
| Mar 31, 2023 | 124.39 Mn |
| Dec 31, 2022 | 135.30 Mn |
| Sep 30, 2022 | 147.66 Mn |
| Jun 30, 2022 | 155.68 Mn |
| Mar 31, 2022 | 167.00 Mn |
| Dec 31, 2021 | 175.36 Mn |
| Sep 30, 2021 | 184.13 Mn |
API Access
Jade Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=JBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "JBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=JBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();